"10.1371_journal.pmed.1000270","plos medicine","2010-05-04T00:00:00Z","Gina Ogilvie; Maureen Anderson; Fawziah Marra; Shelly McNeil; Karen Pielak; Meena Dawar; Marilyn McIvor; Thomas Ehlen; Simon Dobson; Deborah Money; David M Patrick; Monika Naus","University of British Columbia, Vancouver, Canada; BC Centre for Disease Control, Vancouver, Canada; Dalhousie University, Halifax, Canada","ICMJE criteria for authorship read and met: GO MA FM SM KP MD MM TE SD DM DMP MN. Agree with the manuscript's results and conclusions: GO MA FM SM KP MD MM TE SD DM DMP MN. Designed the experiments/the study: GO MA FM SM KP SD DMP MN. Analyzed the data: GO MA MD. Collected data/did experiments for the study: GO MA TE. Enrolled patients: GO MA MN. Wrote the first draft of the paper: GO. Contributed to the writing of the paper: GO FM SM KP MM TE SD DM DMP MN. Revision of document for important intellectual content, and approval of final version: MD. Reviewed the final version of the paper: SD.","SM is a member of the Canadian National Advisory Committee on Immunization. SD is presently a member of the British Columbia Immunization Sub-committee which advises the provincial government on practical issues related to the implementation of publicly funded immunization programs. From 2000 to 2008 SD was a member of the National Advisory Committee on Immunization for Canada. In 2008 SD attended an Advisory Board for Merck for a vaccine not yet licensed. This was not the vaccine used in the Provincial HPV vaccine program discussed in this paper. SD was paid an honorarium for my work on this advisory board.","2010","05","Gina Ogilvie","GO",12,TRUE,NA,NA,3,1,TRUE,TRUE,FALSE,0,NA,FALSE
